IDA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
IDA is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has constructive analyst support and favorable long-term utility characteristics, but the current technical setup is weak, there is no fresh news catalyst, and proprietary trading signals do not confirm an immediate entry. Since the investor is impatient and does not want to wait for an ideal pullback, the current pre-market level is still not compelling enough to call a direct buy.
IDA is trading at 142.49 in pre-market, below the pivot level of 144.703 and closer to support at 141.341. The MACD histogram is -0.538 and negatively expanding, which shows short-term downside momentum. RSI_6 at 35.698 is neutral-to-weak, and the moving averages are converging, suggesting a lack of clear trend strength. Overall, the chart is slightly bearish to range-bound rather than signaling a clean breakout. The next important levels are S1 at 141.341 and R1 at 148.065.
["Recent analyst target increases from Barclays and Mizuho point to continued upside expectations.", "Barclays said Idacorp has its best and accelerating growth prospects versus the group.", "Utilities have recently outperformed broader market benchmarks in analyst commentary.", "The company is viewed by some analysts as having attractive valuation and industry-leading rate base growth."]
["No news in the recent week, so there is no fresh event-driven catalyst.", "Short-term technical momentum is negative, with a weakening MACD.", "The stock is trading below its pivot level and near support, showing no breakout confirmation.", "Similar candlestick pattern analysis suggests negative next-month performance.", "No notable insider, hedge fund, or congress trading activity supports the stock."]
No usable latest-quarter financial snapshot was provided because the financial data section returned an error. As a result, I cannot confirm the latest quarter season or assess recent revenue, earnings, or growth trends from the supplied data.
Analyst sentiment is overall positive. Barclays and Mizuho are bullish, with Barclays raising its target to $167 and calling out accelerating growth prospects, while Morgan Stanley remains Overweight despite small target adjustments. Wells Fargo is the main bearish outlier with an Underweight rating and a much lower target of $121. The Wall Street view is therefore mixed but tilted bullish, with multiple Overweight/Outperform ratings and rising targets outweighing the lone underweight stance.
